1-anilino-8-naphthalenesulfonate has been researched along with Coronary Restenosis in 1 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yu, X | 1 |
Lu, J | 1 |
Li, J | 1 |
Guan, W | 1 |
Deng, S | 1 |
Deng, Q | 1 |
Ye, H | 1 |
Han, W | 1 |
Yu, Y | 1 |
Zhang, R | 1 |
1 other study available for 1-anilino-8-naphthalenesulfonate and Coronary Restenosis
Article | Year |
---|---|
Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis.
Topics: Atherosclerosis; Biomarkers; Coronary Restenosis; Female; Follow-Up Studies; Humans; Lipase; Lipopro | 2019 |